Our Commitment
We are committed to developing and commercializing therapeutics that improve the health of people affected by chronic inflammatory and fibrotic diseases.
Learn More
Our Company
We are a clinical-stage company focused on treating inflammatory and fibrotic diseases by targeting the endocannabinoid system.
Our Science
Our focus on the endocannabinoid system is backed by an ever-expanding body of research and robust underlying science based on the endocannabinoid system as a master regulator of inflammation and fibrosis in the body.
Learn MoreLeading Endocannabinoid System-Targeting Pipeline
2
Lead Compounds
3
Ongoing Late-Stage Clinical Studies
600+
Compounds in Library
>350k
People Affected by Target Diseases
Join Our Team
Corbus is a tight-knit team of nearly 100 employees and we are seeking people who are high-achievers, innovative, creative and, above all else, passionate about what they do, to join our team.
View Open Positions
View All News
Recent News
Investor Information
CRBP
Nasdaq
Volume
Market Cap
Change
